
Join to view full profile
2799 W Grand BlvdCFP5Detroit, MI 48202
Phone+1 313-916-2600
Fax+1 313-916-7911
Dr. Hwang is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MichiganFellowship, Hematology and Medical Oncology, 2005 - 2008
University of MichiganResidency, Internal Medicine, 2001 - 2004
University of Michigan Medical SchoolClass of 2001
Certifications & Licensure
MI State Medical License 2001 - 2029
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Sunquest Laboratory, Sunquest Information Systems, Inc., 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Outgoing Public Health Reporting from EpicCare Functionality, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET Start of enrollment: 2019 Sep 05
Roles: Contact
- Utilization of Educational Interventions in Completion of Genetic Testing in Black Patients With High-Risk Prostate Cancer Start of enrollment: 2025 Jan 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Association between smoking, tumor genetics, and outcomes in men with metastatic prostate cancer.Christopher Choi, Matthew Labriola, Nicholas Henderson, Alec Chu, Clara Hwang
Prostate Cancer and Prostatic Diseases. 2026-09-05 - Author Correction: Casdatifan shows durable response linked to HIF-2α biology in kidney cancer.Toni K Choueiri, Jaime Merchán, Amita Patnaik, Alexandra Drakaki, Brian I Rini
Nature. 2026-08-01 - Casdatifan shows durable response linked to HIF-2α biology in kidney cancer.Toni K Choueiri, Jaime Merchán, Amita Patnaik, Alexandra Drakaki, Brian I Rini
Nature. 2026-08-01
Press Mentions
Closing the Cancer Disparities Gap Broadened by COVID-19November 10th, 2022
Study of Cancer Patients and COVID-19 Highlights Health DisparitiesJuly 21st, 2021
Antiandrogens Augment Growing Armamentarium in Metastatic Prostate CancerJanuary 3rd, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









